Verax Biomedical (United States)
- Research works
- 37 ▼ 69% vs 2018-21
- Citations
- 479 13.0 per fractional work
- Top-10% rate
- 7.1% all institutions 10.0%
- Open access
- 25% world 40%
- International
- 12% world 18%
Not ranked overall: Verax Biomedical (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Verax Biomedical (United States) work in?
In all years, 34% of research at Verax Biomedical (United States) is in Life Sciences, 27% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (34%), Medicine (25%), Engineering (17%). It does 1.8× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 15 fields, with their numbers
- Life Sciences1233.9%
- Health Sciences1027.2%
- Medicine925.4%
- Dentistry00.9%
- Health Professions00.9%
- Physical Sciences1027.1%
- Engineering616.8%
- Computer Science38.5%
- Earth and Planetary Sciences00.9%
- Chemistry00.5%
- Environmental Science00.5%
- Social Sciences411.8%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Computer Science, 6.4×. Every wedge is a field page.
All 7 fields, with their numbers
- Computer Science6.40×3 works
- Decision Sciences5.72×0 works
- Medicine1.68×2 works
- Neuroscience1.14×0 works
- Economics, Econometrics and Finance1.03×0 works
- Biochemistry, Genetics and Molecular Biology0.53×0 works
- Social Sciences0.44×0 works
Who are the top researchers at Verax Biomedical (United States)?
Ranked on the quality score, Remo P. Vallejo lead among researchers whose main affiliation is Verax Biomedical (United States).
- 1
Remo P. Vallejo
United States · #2,387,791 worldwide 532 citations · 17 works
Which keywords describe research at Verax Biomedical (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cell Culture, Biopharmaceutical Production, Glycosylation, Mammalian Cells, Recombinant Protein, Blood Transfusion, Biopharmaceuticals and Therapeutic Antibodies.
- Pancreatic Islets
- Gene Expression
- Cardiovascular Disease
- Heart Failure
- Donor Behavior
- Globalization
- Supply Chain Management
- Machine Learning
- Tranexamic Acid
- Anemia
- Tissue Engineering
- Bioprinting
- Stability
- Therapeutic Antibodies
- Blood Transfusion
- Mammalian Cells
- Biopharmaceutical Production
- Cell Culture
- Glycosylation
- Recombinant Protein
- Biopharmaceuticals
- Protein Aggregation
- Regenerative Medicine
- Hemorrhage
- Risk Factors
- Critical Care
- Inflammation
- Security
- Diabetes Mellitus
- Blood Donation
- Epidemiology
- Adversarial Examples
- Deep Learning
- Genomic Integration
- ß-Cell Dysfunction
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 35 words, with their numbers
- Cell Culture7▲ 168×2 topics
- Biopharmaceutical Production5▲ 175×2 topics
- Glycosylation5▲ 58×2 topics
- Mammalian Cells4▲ 302×1 topic
- Recombinant Protein4▲ 302×1 topic
- Blood Transfusion3▲ 159×2 topics
- Biopharmaceuticals3▲ 119×2 topics
- Therapeutic Antibodies3▲ 64×2 topics
- Protein Aggregation3▲ 92×1 topic
- Stability3▲ 38×1 topic
- Regenerative Medicine2▲ 32×2 topics
- Bioprinting2▲ 145×1 topic
- Hemorrhage2▲ 90×2 topics
- Tissue Engineering2▲ 12×1 topic
- Risk Factors2▲ 5.5×4 topics
- Anemia2▲ 45×1 topic
- Critical Care2▲ 24×2 topics
- Tranexamic Acid2▲ 249×1 topic
- Inflammation2▲ 2.1×8 topics
- Machine Learning2▲ 2.2×3 topics
- Security2▲ 11×3 topics
- Supply Chain Management2▲ 8.8×2 topics
- Diabetes Mellitus2▲ 18×4 topics
- Globalization1▲ 1.97×4 topics
- Blood Donation1▲ 227×1 topic
- Donor Behavior1▲ 227×1 topic
- Epidemiology1▼ 0.82×5 topics
- Heart Failure1▲ 6.9×4 topics
- Adversarial Examples1▲ 156×1 topic
- Cardiovascular Disease1▲ 2.5×6 topics
- Deep Learning1▲ 1.29×1 topic
- Gene Expression1▲ 4.5×2 topics
- Genomic Integration1▲ 26×2 topics
- Pancreatic Islets1▲ 41×1 topic
- ß-Cell Dysfunction1▲ 41×1 topic
Which research topics does Verax Biomedical (United States) publish most on?
By volume in 2022-now: Adversarial Robustness in Machine Learning, Digital and Cyber Forensics, Privacy-Preserving Technologies in Data and Security and Verification in Computing.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Adversarial Robustness in Machine Learning Artificial Intelligence 1 works
- 2 Digital and Cyber Forensics Information Systems 1 works
- 3 Privacy-Preserving Technologies in Data Artificial Intelligence 1 works
- 4 Security and Verification in Computing Artificial Intelligence 0 works
- 5 Scientific Computing and Data Management Information Systems and Management 0 works
- 6 Retinal and Macular Surgery Radiology, Nuclear Medicine and Imaging 0 works
- 7 Digital Imaging in Medicine Public Health, Environmental and Occupational Health 0 works
- 8 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
- 9 Nutrition and Health in Aging Physiology 0 works
- 10 Software System Performance and Reliability Computer Networks and Communications 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Verax Biomedical (United States)'s research output changed?
Output in 2022-2025 was 69% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Verax Biomedical (United States) as a percentage of every work published that year, 0.000015% in 2024.
Fractional works of Verax Biomedical (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Marlborough
- Boston Scientific (United States)
- Sumitomo Dainippon Pharma (United States)
- Sunovion (United States)
- Hologic (United States)
- Hottinger Baldwin Messtechnik (United States)
- Advanced Cell Technology (United States)
- Phio Pharmaceuticals (United States)
- CardioFocus (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Verax Biomedical (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.